We are live on ! Find out more

377 hedge funds and large institutions have $2.19B invested in Chemours in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 87 increasing their positions, 134 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more funds holding in top 10

Funds holding in top 10: 310 (+7)

88% more capital invested

Capital invested by funds: $1.16B → $2.19B (+$1.03B)

75% more call options, than puts

Call options by funds: $32.8M | Put options by funds: $18.8M

23% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 43

2% more funds holding

Funds holding: 371377 (+6)

1.76% less ownership

Funds ownership: 77.86%76.1% (-1.8%)

35% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 134

Holders
377
Holders Change
+6
Holders Change %
+1.62%
% of All Funds
10.06%
Holding in Top 10
10
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+233.33%
% of All Funds
0.27%
New
53
Increased
87
Reduced
134
Closed
43
Calls
$32.8M
Puts
$18.8M
Net Calls
+$14M
Net Calls Change
+$16.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.99M +$5.2K +455 +0.4%
NFA
102
Nationwide Fund Advisors
Ohio
$1.92M
AIMCA
103
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.91M +$1.37M +119,610 New
CEP
104
Chicago Equity Partners
Illinois
$1.91M +$1.36M +119,390 New
Jacobs Levy Equity Management
105
Jacobs Levy Equity Management
New Jersey
$1.89M +$135K +11,800 +11%
AC
106
Ascend Capital
California
$1.71M -$6.98M -611,390 -85%
EVM
107
Eaton Vance Management
Massachusetts
$1.68M -$489K -42,823 -29%
Barclays
108
Barclays
United Kingdom
$1.61M +$1.02M +89,522 +792%
HHMI
109
Howard Hughes Medical Institute
Maryland
$1.6M +$531K +46,489 +87%
GT
110
Glenmede Trust
Pennsylvania
$1.56M -$24.6K -2,158 -2%
BA
111
BlackRock Advisors
Delaware
$1.52M +$112K +9,766 +11%
SO
112
STRS Ohio
Ohio
$1.52M +$30.8K +2,700 +3%
ASRS
113
Arizona State Retirement System
Arizona
$1.5M -$3.43K -300 -0.3%
Thrivent Financial for Lutherans
114
Thrivent Financial for Lutherans
Minnesota
$1.48M +$43.9K +3,840 +4%
MAM
115
Martingale Asset Management
Massachusetts
$1.47M +$1.05M +92,054 New
BlackRock
116
BlackRock
New York
$1.33M -$543K -47,561 -36%
LSERS
117
Louisiana State Employees Retirement System
Louisiana
$1.28M -$2.28K -200 -0.2%
T. Rowe Price Associates
118
T. Rowe Price Associates
Maryland
$1.26M -$429K -37,600 -32%
GCP
119
GSA Capital Partners
United Kingdom
$1.2M +$856K +74,912 New
CAM
120
Capstone Asset Management
Texas
$1.1M -$6.97K -610 -0.9%
MAM
121
Meeder Asset Management
Ohio
$1.1M +$26.5K +2,322 +4%
EA
122
Emerald Acquisition
Washington
$1.04M +$378K +33,057 +104%
TRSOTSOK
123
Teachers Retirement System of the State of Kentucky
Kentucky
$982K +$61.7K +5,400 +10%
ANTB
124
AMG National Trust Bank
Colorado
$942K +$42.1K +3,685 +7%
CGH
125
Crossmark Global Holdings
Texas
$942K +$213K +18,610 New

CC Hedge Fund Activity: Q3 2016 in Review

377 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2016, worth a combined $2.19B — up 88% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new CC positions and 43 closed out — a net gain of 10 holders — while 87 added to existing stakes and 134 trimmed.

The largest buyer was Systematic Financial Management, opening a new position worth an estimated $34.8M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $39.1M sold.

  • 377 institutional investors held Chemours (CC) as of Q3 2016, up from 371 in Q2 2016.
  • Funds reported $2.19B of Chemours stock for Q3 2016, up 88% quarter-over-quarter.
  • 53 funds opened new Chemours positions in Q3 2016 and 43 closed out, a net change of +10 holders.
  • The largest Chemours buyer in Q3 2016 was Systematic Financial Management, an estimated $34.8M added.
  • The largest Chemours seller in Q3 2016 was Capital Research Global Investors, an estimated $39.1M sold.

Based on aggregated 13F filings for Q3 2016.